282 related articles for article (PubMed ID: 8864580)
21. Structure and immune recognition of HLA-B27 antigens: implications for disease association.
López de Castro JA; Bragado R; Lauzurica P; López D; Rojo S
Scand J Rheumatol Suppl; 1990; 87():21-31. PubMed ID: 1701918
[TBL] [Abstract][Full Text] [Related]
22. Immunogenetic basis of the seronegative spondyloarthropathies.
Ivanyi P
Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871
[TBL] [Abstract][Full Text] [Related]
23. Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands.
Martín-Esteban A; Gómez-Molina P; Sanz-Bravo A; López de Castro JA
J Biol Chem; 2014 Feb; 289(7):3978-90. PubMed ID: 24352655
[TBL] [Abstract][Full Text] [Related]
24. A molecular insight on the association of HLA-B27 with spondyloarthropathies.
Martí M; Alvarez I; López de Castro JA
Curr Rheumatol Rep; 1999 Oct; 1(1):78-85. PubMed ID: 11123019
[TBL] [Abstract][Full Text] [Related]
25. Immunogenetics of the spondyloarthropathies.
Ivanyi P
Curr Opin Rheumatol; 1993 Jul; 5(4):436-45. PubMed ID: 8357740
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.
Seregin SS; Rastall DP; Evnouchidou I; Aylsworth CF; Quiroga D; Kamal RP; Godbehere-Roosa S; Blum CF; York IA; Stratikos E; Amalfitano A
Autoimmunity; 2013 Dec; 46(8):497-508. PubMed ID: 24028501
[TBL] [Abstract][Full Text] [Related]
27. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Lamas JR; Paradela A; Roncal F; López de Castro JA
Arthritis Rheum; 1999 Sep; 42(9):1975-85. PubMed ID: 10513815
[TBL] [Abstract][Full Text] [Related]
28. Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.
de Vries DD; Dekker-Saeys AJ; Gyodi E; Bohm U; Ivanyi P
Ann Rheum Dis; 1992 Jun; 51(6):783-9. PubMed ID: 1616364
[TBL] [Abstract][Full Text] [Related]
29. [New aspects in the pathogenesis of Bechterew disease].
Märker-Hermann E; Sucké B; Meyer zum Büschenfelde KH
Z Rheumatol; 1996; 55(1):4-18. PubMed ID: 8868146
[TBL] [Abstract][Full Text] [Related]
30. [The immunogenetics of ankylosing spondylitis].
Toussirot E; Wendling D
Rev Med Interne; 2006 Oct; 27(10):762-71. PubMed ID: 16782239
[TBL] [Abstract][Full Text] [Related]
31. HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility.
Lopez De Castro JA
Clin Rheumatol; 1996 Jan; 15 Suppl 1():67-71. PubMed ID: 8835507
[TBL] [Abstract][Full Text] [Related]
32. Biochemical features of HLA-B27 and antigen processing.
Powis SJ; Santos SG; Antoniou AN
Adv Exp Med Biol; 2009; 649():210-6. PubMed ID: 19731631
[TBL] [Abstract][Full Text] [Related]
33. Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis.
Reveille JD; Maganti RM
Adv Exp Med Biol; 2009; 649():159-76. PubMed ID: 19731628
[TBL] [Abstract][Full Text] [Related]
34. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility.
Martinez-Borra J; Gonzalez S; López-Vazquez A; Gelaz MA; Armas JB; Kanga U; Mehra NK; López-Larrea C
Hum Immunol; 2000 Feb; 61(2):131-9. PubMed ID: 10717805
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of the susceptibility difference between HLA-B*27:02/04/05 and HLA-B*27:06/09 to ankylosing spondylitis: substitution analysis, MD simulation, QSAR modelling, and in vitro assay.
Cheng X; Mei Y; Ji X; Xue Q; Chen D
SAR QSAR Environ Res; 2016 May; 27(5):409-25. PubMed ID: 27228481
[TBL] [Abstract][Full Text] [Related]
36. Possible protective role of HLA-B*2706 for ankylosing spondylitis.
Ren EC; Koh WH; Sim D; Boey ML; Wee GB; Chan SH
Tissue Antigens; 1997 Jan; 49(1):67-9. PubMed ID: 9027969
[TBL] [Abstract][Full Text] [Related]
37. Differences in Cellular Clearing Mechanisms of Aggregates of Two Subtypes of HLA-B27.
Thakur AK; Luthra-Guptasarma M
Front Immunol; 2021; 12():795053. PubMed ID: 35082784
[TBL] [Abstract][Full Text] [Related]
38. T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Fiorillo MT; Sorrentino R
Adv Exp Med Biol; 2009; 649():255-62. PubMed ID: 19731635
[TBL] [Abstract][Full Text] [Related]
39. HLA B27 in health and disease: a double-edged sword?
Bowness P
Rheumatology (Oxford); 2002 Aug; 41(8):857-68. PubMed ID: 12154202
[TBL] [Abstract][Full Text] [Related]
40. [Ankylosing spondylitis and heterogenity of HLA-B27 in Chinese].
Lin J; Lu H; Feng C
Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):333-5. PubMed ID: 9594171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
